Skip to main content
TipRanks
Go Ultimate75% OFF
ARTBIO logo

ARTBIO: Valuation, Funding & Investors

Kendall Sq c/o Alexandria LaunchLabs B200, Suite 001 Cambridge, Massachusetts 02139, UShttps://www.artbio.com/Therapeutics

ARTBIO is a biotechnology company specializing in the development of alpha radioligand therapies. The company is focused on advancing its lead asset, AB001, through clinical development and progressing additional programs toward investigational new drug (IND) readiness. ARTBIO also emphasizes expanding its manufacturing and supply chain infrastructure, utilizing its proprietary generator technology to enhance its operations.

Leadership & Board

Current Number of Employees
77
Current LinkedIn Followers
13,333

Latest Estimated Valuation

Total Amount Raised
$132M
Total Funding Rounds
1
Latest Funding Amount
$132M
Latest Funding Round
Series B

Employee Trend

ARTBIO had 77 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.

77Latest Employee Count
0(0.00%)Week-Over-Week Change
020406080Feb 16, 2026Mar 02, 2026Mar 16, 2026Mar 30, 2026Apr 13, 2026May 04, 2026May 18, 2026Jun 01, 2026Jun 15, 2026Jun 29, 2026Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Social Trend

ARTBIO had 13,333 followers as of November 16, 2026. The number of followers increased by 20 (0.15%) week-over-week.

13,333Latest Followers Count
20(0.15%)Week-Over-Week Change
05,00010,00015,00020,000Feb 16, 2026Mar 02, 2026Mar 16, 2026Mar 30, 2026Apr 13, 2026May 04, 2026May 18, 2026Jun 01, 2026Jun 15, 2026Jun 29, 2026Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Jul 29, 2025Series B$132.00M―

Investors

Similar Companies

A snapshot of private companies similar to ARTBIO, helping you discover and navigate related company profiles.

Related News and Analysis